Article

Episode 2: How On-Dose Technologies Mitigate Safety Risks and Reduce Product Diversion and Counterfeiting

   

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Derrick Gastineau
Related Content
Most Favored Nation webinar
August 29th 2025

Pharmaceutical Executive Presents The Most Favored Nation Mandate

PharmExec Staff
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 29th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 29th 2025

Amylyx Pharmaceuticals Discontinues Orion Program of Ax0035

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 29th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Lamine Mbow
August 29th 2025

Leading Science-Driven Organizations: Q&A with Lamine Mbow

Mike Hollan
Stock.adobe.com
August 29th 2025

FDA Accepts New Drug Application for Gadoquatrane

Nicholas Jacobus